Diurnal Group PLC Director Dealings (4454Y)

TIDMDNL

RNS Number : 4454Y

Diurnal Group PLC

12 May 2021

12 May 2021

Diurnal Group plc

("Diurnal" or the "Company")

Director Dealings

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces the following Directors' dealings undertaken for tax planning purposes:

Richard Ross, Chief Scientific Officer sold 22,000 Ordinary Shares and his wife (Sarah Ross) sold 20,000 Ordinary Shares at a price of 66.5 pence per Ordinary Share; his and his wife's ISAs purchased 22,000 Ordinary Shares and 20,000 Ordinary Shares respectively at a price of 66.55 pence per Ordinary Share. Following the transactions, the total beneficial interest of Richard Ross and his connected parties remains unchanged at 2,221,093 Ordinary Shares, representing 1.3% of the total voting rights as at 12 May 2021.

Details of the full notifications received by the Company are set out below:

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                            Richard Ross 
      -----------------------------  --------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------- 
 a)    Position/status                Chief Scientific Officer 
      -----------------------------  --------------------------------------------- 
 b)    Initial notification           Initial notification 
        /Amendment 
      -----------------------------  --------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------- 
 a)    Name                           Diurnal Group plc 
      -----------------------------  --------------------------------------------- 
 b)    LEI                            213800I2HNUNZN1LDH29 
      -----------------------------  --------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ---------------------------------------------------------------------------- 
 a)    Description of the             Ordinary shares of 5 pence each in 
        financial instrument,          Diurnal Group plc 
        type of instrument 
 
       Identification code            GB00BDB6Q760 
 
 b)    Nature of the transaction      Sale and purchase of ordinary shares 
      -----------------------------  --------------------------------------------- 
 c)    Price(s) and volume(s) 
                                            ---------------------  ---------- 
                                             Price(s)               Volume(s) 
                                            ---------------------  ---------- 
                                             Sale 66.5p             22,000 
     Purchase 66.55p                                                 22,000 
   --------------------------------------------------------------  ---------- 
 
 d)    Aggregated information 
 
  - Aggregated volume            As above 
 
  - Price 
 
 e)    Date of the transaction        12 May 2021 
      -----------------------------  --------------------------------------------- 
 f)    Place of the transaction       XLON 
      -----------------------------  --------------------------------------------- 
 
 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                             Sarah Ross 
      ------------------------------  -------------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------- 
 a)    Position/status                 Closely associated person to an Executive 
                                        Director 
      ------------------------------  -------------------------------------------------- 
 b)    Initial notification            Initial notification 
        /Amendment 
      ------------------------------  -------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------------- 
 a)    Name                            Diurnal Group plc 
      ------------------------------  -------------------------------------------------- 
 b)    LEI                             213800I2HNUNZN1LDH29 
      ------------------------------  -------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ---------------------------------------------------------------------------------- 
 a)    Description of the              Ordinary shares of 5 pence each in 
        financial instrument,           Diurnal Group plc 
        type of instrument 
 
       Identification code             GB00BDB6Q760 
 
 b)    Nature of the transaction       Sale and purchase of ordinary shares 
      ------------------------------  -------------------------------------------------- 
 c)    Price(s) and volume(s) 
                                             ------------------------  ------------- 
                                              Price(s)                  Volume(s) 
                                             ------------------------  ------------- 
                                              Sale 66.5p                20,000 
     Purchase 66.55p                                                     20,000 
   ------------------------------------------------------------------  ------------- 
 
 d)    Aggregated information 
 
  - Aggregated volume             As above 
 
  - Price 
 
 e)    Date of the transaction         12 May 2021 
      ------------------------------  -------------------------------------------------- 
 f)    Place of the transaction        XLON 
      ------------------------------  -------------------------------------------------- 
 
 
 For further information, please visit www.diurnal.co.uk or 
  contact: 
 
                                                   [phone] 
 Diurnal Group plc                                  1000 
 Martin Whitaker, Chief Executive Officer 
 Richard Bungay, Chief Financial Officer 
 
 Panmure Gordon (UK) Limited (Nominated Adviser    [phone] 
  and Sole Broker)                                  2500 
 Corporate Finance: Freddy Crossley, Emma Earl 
 Corporate Broking: Rupert Dearden 
 
                                                   [phone] 
 FTI Consulting (Media and Investor Relations)      1000 
 Simon Conway 
 Victoria Foster Mitchell 
 Alex Davis 
 

Notes to Editors

About Diurnal Group plc

Diurnal Group plc is a European, UK-headquartered, specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism and hypothyroidism. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

For further information about Diurnal, please visit www.diurnal.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVRELIFLIL

(END) Dow Jones Newswires

May 12, 2021 12:32 ET (16:32 GMT)